{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:56:06Z","timestamp":1792526166189,"version":"4.5.0"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["K-119992"],"award-info":[{"award-number":["K-119992"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["FK-129117"],"award-info":[{"award-number":["FK-129117"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00012"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00012"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Human Capacities Hungary","award":["20391-3\/2018\/FEKUSTRAT"],"award-info":[{"award-number":["20391-3\/2018\/FEKUSTRAT"]}]},{"name":"Ministry of Human Capacities Hungary","award":["EFOP-3.6.2-16-2017-00006"],"award-info":[{"award-number":["EFOP-3.6.2-16-2017-00006"]}]},{"name":"HU-RO Cross-Border Cooperation Programmes","award":["HU-RO\/0802\/011_AF HURO-CARDIOPOL"],"award-info":[{"award-number":["HU-RO\/0802\/011_AF HURO-CARDIOPOL"]}]},{"name":"HU-RO Cross-Border Cooperation Programmes","award":["HURO\/1001\/086\/2.2.1"],"award-info":[{"award-number":["HURO\/1001\/086\/2.2.1"]}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/toxsci\/kfy299","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T17:48:26Z","timestamp":1544723306000},"page":"365-380","source":"Crossref","is-referenced-by-count":63,"title":["Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native\n                    <i>I<\/i>\n                    Kr Currents and on Cardiac Action Potential"],"prefix":"10.1093","volume":"168","author":[{"given":"P\u00e9ter","family":"Orvos","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"},{"name":"Department of Ophthalmology, University of Szeged, Szeged H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Kohajda","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"},{"name":"MTA-SZTE Research Group for Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozefina","family":"Szlov\u00e1k","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Gazdag","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"\u00c1rp\u00e1dffy-Lovas","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Geramipour","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"T\u00e1losi","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Jost","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"},{"name":"MTA-SZTE Research Group for Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged H-6720, Hungary"},{"name":"Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, Szeged H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Varr\u00f3","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"},{"name":"MTA-SZTE Research Group for Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged H-6720, Hungary"},{"name":"Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, Szeged H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Vir\u00e1g","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Faculty of Medicine"},{"name":"MTA-SZTE Research Group for Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged H-6720, Hungary"},{"name":"Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, Szeged H-6720, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with hERG and is associated with cardiac arrhythmia","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1476-5381.2011.01378.x","article-title":"hERG subunit composition determines differential drug sensitivity","volume":"164","author":"Abi-Gerges","year":"2011","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1476-5381.2011.01649_1.x","article-title":"Guide to Receptors and Channels (GRAC), 5th edition","volume":"164(Suppl. 1)","author":"Alexander","year":"2011","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B5","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1016\/j.bmcl.2009.07.047","article-title":"Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs","volume":"19","author":"Aslanian","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0704881","article-title":"Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: Role of repolarization reserve","volume":"137","author":"Biliczki","year":"2002","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.bjp.0701879","article-title":"Effects of cetirizine on the delayed K+ currents in cardiac cells: Comparison with terfenadine","volume":"124","author":"Carmeliet","year":"1998","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3565(25)31686-1","article-title":"Effects of verapamil on rapid Na channel-dependent action potentials of K+-depolarized ventricular fibers","volume":"209","author":"Chen","year":"1979","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0026-895X(24)13071-4","article-title":"hERG and KvLQT1\/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers","volume":"54","author":"Chouabe","year":"1998","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)35285-1","article-title":"Loratadine blockade of K(+) channels in human heart: Comparison with terfenadine under physiological conditions","volume":"292","author":"Crumb","year":"2000","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel","volume":"81","author":"Crumb","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: Pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu","year":"2016","journal-title":"Curr. Cardiol. Rev"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/187152708784083867","article-title":"Ion channel screening technology","volume":"7","author":"Dabrowski","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.97.2.204","article-title":"Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval","volume":"97","author":"Drolet","year":"1998","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005344-199707000-00007","article-title":"Comparative effects of loratadine and terfenadine on cardiac K+ channels","volume":"30","author":"Ducic","year":"1997","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrd2552","article-title":"High-throughput electrophysiology: An emerging paradigm for ion-channel screening and physiology","volume":"7","author":"Dunlop","year":"2008","journal-title":"Nat. Rev. Drug Discov"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3565(25)31391-1","article-title":"The voltage- and time-dependent effects of (\u2212)-verapamil on the slow inward current in isolated cat ventricular myocardium","volume":"207","author":"Ehara","year":"1978","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/17460441.2012.682056","article-title":"HTS techniques for patch clamp-based ion channel screening\u2014advances and economy","volume":"7","author":"Farre","year":"2012","journal-title":"Expert Opin. Drug Discov"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B19","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.ddtec.2008.12.004","article-title":"Ion channel screening\u2014automated patch clamp on the rise","volume":"5","author":"Farre","year":"2008","journal-title":"Drug Discov. Today Technol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/138620709787047966","article-title":"Port-a-patch and patchliner: High fidelity electrophysiology for secondary screening and safety pharmacology","volume":"12","author":"Farre","year":"2009","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/14728222.11.4.557","article-title":"Automated ion channel screening: Patch clamping made easy","volume":"11","author":"Farre","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B22","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1016\/S0006-3495(02)75646-4","article-title":"Whole cell patch clamp recording performed on a planar glass chip","volume":"82","author":"Fertig","year":"2002","journal-title":"Biophys. J"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejphar.2003.12.028","article-title":"Differential effect of hERG blocking agents on cardiac electrical alternans in the guinea pig","volume":"486","author":"Fossa","year":"2004","journal-title":"Eur. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vascn.2004.02.006","article-title":"Developing a strategy for the nonclinical assessment of proarrhythmic risk of pharmaceuticals due to prolonged ventricular repolarization","volume":"49","author":"Guth","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2008.05.009","article-title":"The hERG potassium channel and hERG screening for drug-induced torsades de pointes","volume":"119","author":"Hancox","year":"2008","journal-title":"Pharmacol. Ther"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B26","first-page":"bar017.","article-title":"hERGAPDbase: A database documenting hERG channel inhibitory potentials and APD-prolongation activities of chemical compounds","volume":"2011","author":"Hishigaki","year":"2011","journal-title":"Database J. Biol. Databases Curation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1113\/jphysiol.1945.sp004114","article-title":"Resting and action potentials in single nerve fibres","volume":"104","author":"Hodgkin","year":"1945","journal-title":"J. Physiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.hrthm.2008.05.006","article-title":"QT prolongation is an unreliable predictor of ventricular arrhythmia","volume":"5","author":"Hondeghem","year":"2008","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2008.01.016","article-title":"Use and abuse of QT and TRIaD in cardiac safety research: Importance of study design and conduct","volume":"584","author":"Hondeghem","year":"2008","journal-title":"Eur. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FJC.0b013e3182135e91","article-title":"Drug-induced QTC prolongation dangerously underestimates proarrhythmic potential: Lessons from terfenadine","volume":"57","author":"Hondeghem","year":"2011","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B31","doi-asserted-by":"crossref","first-page":"44690","DOI":"10.1074\/jbc.M408344200","article-title":"Cardiac IKr channels minimally comprise hERG 1a and 1b subunits","volume":"279","author":"Jones","year":"2004","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B32","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.yjmcc.2012.02.002","article-title":"Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG","volume":"52","author":"Jonsson","year":"2012","journal-title":"J. Mol. Cell. Cardiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bph.12228","article-title":"ORM-10103, a novel specific inhibitor of the Na+\/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart","volume":"170","author":"Jost","year":"2013","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B34","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCULATIONAHA.105.550111","article-title":"Restricting excessive cardiac action potential and QT prolongation: A vital role for IKs in human ventricular muscle","volume":"112","author":"Jost","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.vascn.2004.06.003","article-title":"Variability in the measurement of hERG potassium channel inhibition: Effects of temperature and stimulus pattern","volume":"50","author":"Kirsch","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B36","doi-asserted-by":"crossref","first-page":"e0166041.","DOI":"10.1371\/journal.pone.0166041","article-title":"The effect of a novel highly selective inhibitor of the sodium\/calcium exchanger (NCX) on cardiac arrhythmias in in vitro and in vivo experiments","volume":"11","author":"Kohajda","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00586221","article-title":"Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors","volume":"335","author":"Kohlhardt","year":"1972","journal-title":"Pflugers Arch"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B38","doi-asserted-by":"crossref","first-page":"2100.","DOI":"10.1038\/srep02100","article-title":"MICE models: Superior to the hERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B39","doi-asserted-by":"crossref","first-page":"e53255.","DOI":"10.1371\/journal.pone.0053255","article-title":"Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve","volume":"7","author":"Krist\u00f3f","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B40","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1096\/fj.02-1057fje","article-title":"The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines","volume":"17","author":"Kupershmidt","year":"2003","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/01.RES.81.5.719","article-title":"Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts","volume":"81","author":"Lees-Miller","year":"1997","journal-title":"Circ. Res"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjp.0703777","article-title":"Pharmacological block of the slow component of the outward delayed rectifier current (I(Ks)) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration","volume":"132","author":"Lengyel","year":"2001","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B43","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjp.0707297","article-title":"Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes","volume":"151","author":"Lengyel","year":"2007","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B44","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/CIRCULATIONAHA.113.001883","article-title":"Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity","volume":"127","author":"Liang","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B45","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1440-1681.2006.04487.x","article-title":"Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels","volume":"33","author":"Limberis","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.RES.81.5.870","article-title":"Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current","volume":"81","author":"London","year":"1997","journal-title":"Circ. Res"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/138620708783877735","article-title":"Impact of novel screening technologies on ion channel drug discovery","volume":"11","author":"L\u00fc","year":"2008","journal-title":"Comb. Chem. High Throughput Screen"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B48","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1476-5381.2012.01880.x","article-title":"Does terfenadine-induced ventricular tachycardia\/fibrillation directly relate to its QT prolongation and torsades de pointes?","volume":"166","author":"Lu","year":"2012","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00005344-199903000-00023","article-title":"Terfenadine block of sodium current in canine atrial myocytes","volume":"33","author":"Lu","year":"1999","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005344-200403000-00007","article-title":"The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: Influence of multi-channel block","volume":"43","author":"Martin","year":"2004","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.10.2.319","article-title":"QPatch: The past, present and future of automated patch clamp","volume":"10","author":"Mathes","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/40882","article-title":"A minK-hERG complex regulates the cardiac potassium current I(Kr)","volume":"388","author":"McDonald","year":"1997","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.vascn.2009.04.198","article-title":"Effect of compound plate composition on measurement of hERG current IC(50) using PatchXpress","volume":"60","author":"Mo","year":"2009","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B54","doi-asserted-by":"crossref","first-page":"73.","DOI":"10.3389\/fphar.2011.00073","article-title":"Automated electrophysiology makes the pace for cardiac ion channel safety screening","volume":"2","author":"M\u00f6ller","year":"2011","journal-title":"Front. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/260799a0","article-title":"Single-channel currents recorded from membrane of denervated frog muscle fibres","volume":"260","author":"Neher","year":"1976","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00584247","article-title":"The extracellular patch clamp: A method for resolving currents through individual open channels in biological membranes","volume":"375","author":"Neher","year":"1978","journal-title":"Pfl\u00fcg. Arch. Eur. J. Physiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fitote.2014.11.023","article-title":"Effects of Chelidonium majus extracts and major alkaloids on hERG potassium channels and on dog cardiac action potential\u2014a safety approach","volume":"100","author":"Orvos","year":"2015","journal-title":"Fitoterapia"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B58","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.vascn.2016.05.016","article-title":"Human ex-vivo action potential model for pro-arrhythmia risk assessment","volume":"81","author":"Page","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B59","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0960-894X(03)00196-3","article-title":"Characterization of hERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches","volume":"13","author":"Pearlstein","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B60","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1124\/mol.108.049056","article-title":"Drug binding to the inactivated state is necessary but not sufficient for high-affinity binding to human ether-a-go-go-related gene channels","volume":"74","author":"Perrin","year":"2008","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B61","doi-asserted-by":"crossref","first-page":"3.","DOI":"10.3389\/fphar.2012.00003","article-title":"Toward a new gold standard for early safety: Automated temperature-controlled hERG test on the PatchLiner","volume":"3","author":"Polonchuk","year":"2012","journal-title":"Front. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B62","doi-asserted-by":"crossref","first-page":"1109.","DOI":"10.3389\/fphys.2017.01109","article-title":"Action potential recording and pro-arrhythmia risk analysis in human ventricular trabeculae","volume":"8","author":"Qu","year":"2018","journal-title":"Front. Physiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B63","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.108.798918","article-title":"Repolarization reserve: A moving target","volume":"118","author":"Roden","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B64","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/CIRCULATIONAHA.105.562777","article-title":"Protecting the heart against arrhythmias: Potassium current physiology and repolarization reserve","volume":"112","author":"Roden","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B65","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0002-8703(75)90514-1","article-title":"Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil","volume":"89","author":"Rosen","year":"1975","journal-title":"Am. Heart J"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B66","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium","volume":"167","author":"Sager","year":"2014","journal-title":"Am. Heart J"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.76.1.110","article-title":"Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine","volume":"76","author":"Salata","year":"1995","journal-title":"Circ. Res"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B68","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1161\/CIRCRESAHA.108.185249","article-title":"Physiological properties of hERG 1a\/1b heteromeric currents and a hERG 1b-specific mutation associated with Long-QT syndrome","volume":"103","author":"Sale","year":"2008","journal-title":"Circ. Res"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: hERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B70","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/adt.2014.601","article-title":"Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology","volume":"12","author":"Scheel","year":"2014","journal-title":"Assay Drug Dev. Technol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B71","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.7604285","article-title":"hERG, a human inward rectifier in the voltage-gated potassium channel family","volume":"269","author":"Trudeau","year":"1995","journal-title":"Science"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1476-5381.2011.01367.x","article-title":"Cardiac ventricular repolarization reserve: A principle for understanding drug-related proarrhythmic risk","volume":"164","author":"Varr\u00f3","year":"2011","journal-title":"Br. J. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B73","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vascn.2006.03.011","article-title":"Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve","volume":"54","author":"Vormberge","year":"2006","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1113\/jphysiol.2001.013296","article-title":"A comparison of currents carried by hERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?","volume":"540","author":"Weerapura","year":"2002","journal-title":"J. Physiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B75","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1124\/mol.117.111534","article-title":"The temperature dependence of kinetics associated with drug block of hERG channels is compound-specific and an important factor for proarrhythmic risk prediction","volume":"94","author":"Windley","year":"2018","journal-title":"Mol. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B76","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B77","doi-asserted-by":"crossref","first-page":"e003439.","DOI":"10.1161\/CIRCEP.115.003439","article-title":"Allosteric modulation of Kv11.1 (hERG) channels protects against drug-induced ventricular arrhythmias","volume":"9","author":"Yu","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005344-199710000-00013","article-title":"Multiple modulations of action potential duration by different calcium channel blocking agents in guinea pig ventricular myocytes","volume":"30","author":"Zhang","year":"1997","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"key\n\t\t\t\t2019032711293554500_kfy299-B79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.RES.84.9.989","article-title":"Mechanism of block and identification of the verapamil binding domain to hERG potassium channels","volume":"84","author":"Zhang","year":"1999","journal-title":"Circ. Res"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/168\/2\/365\/28230137\/kfy299.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:35:32Z","timestamp":1775306132000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/168\/2\/365\/5250700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":79,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,12,18]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfy299","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2018,12,18]]}}}